Cancer (Oncology)

Afanat 20® Afatinib Tablets
Afatinib Dimaleate 20mg
- Composition
- Afatinib Dimaleate 20mg
- Dosage form
- Tablet
- Pack size
- Bottle of 28 Tablet
- Manufacturer
- Natco
- Also known as
- Gilotrif, Giotrif, Xovoltib
Supplied against a valid prescription where required, in line with the regulations of the destination country.
Afanat 20 mg contains afatinib, a targeted cancer medicine used for selected cases of non-small cell lung cancer (NSCLC). It may be prescribed for metastatic NSCLC with specific epidermal growth factor receptor (EGFR) mutations and, in certain cases, metastatic squamous NSCLC that has progressed after platinum-based chemotherapy.
As prescribed by a doctor. Dose and duration depend on the condition being treated and the patient. Do not change the dose without medical advice.
Side effects vary by patient. Common and serious side effects are listed in the pack insert. Contact a doctor if you have severe or unexpected symptoms.
Tell your doctor about other medicines you take, allergies, pregnancy or breastfeeding, and any liver or kidney conditions before use.
Store below 30 °C in a dry place, in the original pack, out of reach of children.
Need product documents?
Ask for the pack insert, batch details or a COA with your quote.
Ask on WhatsApp →Related products
Cancer (Oncology)
Cancer (Oncology)
Cancer (Oncology)
Cancer (Oncology)
